Message from the Director-General
My name is Masayuki Takeda, and I was appointed as hospital director on April 1, 2017. My speciality is “urology,” and I am in charge of robot-assisted endoscopic surgery, prostate cancer, dysuria, kidney transplantation, and so on. I worked as hospital vice-director, for medical safety, from 2009 through 2013, and concurrently served as head of the Faculty of Medicine for four years starting in 2013. I intend to maintain and further improve the advanced medical care and medical safety system that has been built by Shinji Shimada, University president , and Hideki Fujii, former hospital director and current director of Kofu Municipal Hospital, and thus I hope your support going forward.
Our hospital was established in 1983 as “Yamanashi Medical University Hospital,” the only Government-specificed high-functioning hospital in Yamanashi Prefecture. On October 1, 2002, the University of Yamanashi and Yamanashi Medical University merged to form a new University of Yamanashi, and at this time, the name of our hospital was changed to “University of Yamanashi Hospital.” On April 1, 2004, the University of Yamanashi became an independent administrative entity as a national university, and thus “national university” was added to the name of University of Yamanashi Hospital in Japanese. Furthermore, our hospital has been designated as a “regional cancer medical care cooperation base hospital,” “liver disease medical care cooperation base hospital,” and so on, and we have developed an intensive medical treatment system that transcends the boundaries between departments.
As for the status of restructuring the hospital, the first stage of construction work was completed in 2015, and our New Ward (368 beds in north and south, Surgical Center, ICU, etc.) began operations in January 2016. The second stage of construction work involving the development of core and environmental infrastructure is currently underway. The Surgical Center in the New Ward is installed with a full-fledged hybrid operating room that features the combination of an operating table with cardiovascular X-ray imaging equipment. Here, it is possible to carry out aortic aneurysm stent graft treatment, as well as transcatheter aortic valve implantation (TAVI), which is a new minimally -invasive procedure for aortic valve stenosis that can be used on patients such as elderly and highly comorbid persons unfit for conventional open surgery. In addition, we have installed an operating room equipped with a 3-tesla high-field MRI scanner, which boasts the highest level of performance in Japan, and an operating room specifically for the da Vinci “Si”® robotic surgical system. In June 2013, prior to the opening of the New Ward, we became the first hospital in Yamanashi Prefecture to start robot-assisted laparoscopic prostate cancer surgery. We have already performed over 150 cases, and these involve hardly any blood transfusions, including autologous transfusions. We began robot-assisted laparoscopic partial nephrectomies on renal carcinomas in September 2016, and have already performed these on over 20 patients. We can perform nephron-sparing surgery on highly challenging cases regarding which conventional laparoscopic surgery would be difficult, and this significantly shortens renal ischemic time, which has the greatest impact on renal function. Going forward, we plan to increase the number of robot-assisted surgeries in areas such as digestive surgery and gynecology. We have installed radiotherapy equipments and many other types of state-of-the-art medical equipment, and are thus working hard to provide high-level, high-quality medical care that is reassuring and safe. As for radiation medical care, we opened the “Yamanashi PET Imaging Diagnostic Clinic” (run by the Shinohara-kai medical corporation) as a development project of the Yamanashi Advanced Molecular Imaging Testing Center. This clinic is located at the southeast corner of the Faculty of Medicine grounds, and is equipped with 2 cutting-edge PET/CT scanners, 1 mammography PET scanner that is special for breast cancer, 1 three-tesla MRI scanner, and 1 cyclotron. It is scheduled to begin operations on May 1, 2017. Furthermore, in 2020, we are planning to open another new ward (250 beds) at our hospital, and thereby further promote high-level medical care including advanced medical care.
Going forward, the staff members and I will work together so that the University of Yamanashi Hospital can remain as a medical institution that is trusted by the people of our region. If you have any opinions or comments, please do not hesitate to share them with us.
Masayuki Takeda, Director-General